Methemoglobinemia and Tumor Lysis Syndrome
Methemoglobinemia and Tumor Lysis Syndrome is a topic indexed in ScholarIQ from OpenAlex.
What is known about Methemoglobinemia and Tumor Lysis Syndrome?
This cluster of papers focuses on the management, treatment, and complications of tumor lysis syndrome (TLS), a potentially life-threatening oncologic emergency characterized by metabolic disturbances. The papers cover various aspects including therapeutic strategies, classification, prophylaxis, risk evaluation, and the use of medications such as rasburicase and dapsone. Additionally, the cluster discusses related conditions like methemoglobinemia and hyperuricemia, particularly in pediatric and adult patients undergoing chemotherapy for hematologic malignancies.
How many works does Methemoglobinemia and Tumor Lysis Syndrome have?
Methemoglobinemia and Tumor Lysis Syndrome has 14,643 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Methemoglobinemia and Tumor Lysis Syndrome have?
Methemoglobinemia and Tumor Lysis Syndrome has 103,422 citations in the OpenAlex counts ScholarIQ stores.
What is the OpenAlex record for Methemoglobinemia and Tumor Lysis Syndrome?
The OpenAlex for Methemoglobinemia and Tumor Lysis Syndrome is on the source record.